Source: Annual Congress 2007 - Pulmonary circulation
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Erdem, S. Oztas, S. Saraç, S. Koklu, O. Tumer, M. Kurutepe (Istanbul, Turkey). The role of plasma D-dimer level to detect pulmonary embolism in COPD exacerbation. Eur Respir J 2007; 30: Suppl. 51, 2111

Member's Comments

No comment yet.

Related content which might interest you: D-dimer testing in patients with acute exacerbation of COPD and suspected pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 The paradoxical association between pulmonary embolism and COPD Source: Eur Respir J, 50 (1) 1700959; 10.1183/13993003.00959-2017 Year: 2017 Pulmonary embolism severity index and D-dimer for risk-stratification of patients with acute pulmonary embolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Relationship between severity of disease and D-dimer levels which were measured with two different methods in pulmonary embolism patients Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases Year: 2009 D-dimer is of limited value in the diagnosis of pulmonary embolism Source: Eur Respir J 2003; 22: Suppl. 45, 218s Year: 2003 Prognostic value of the ECG on admission in patients with acute major pulmonary embolism Source: Eur Respir J 2005; 25: 843-848 Year: 2005 Increased incidence of pulmonary embolism in severe asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 Diagnostic role of d-dimer in suspected pulmonary embolism patients Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001 C reactive protein level in pulmonary embolism. A marker of inflammatory processes in chronic thromboembolic pulmonary hypertension? Source: Eur Respir J 2007; 30: Suppl. 51, 602s Year: 2007 Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 The role of D-dimers with immuno-turbidimetric assay in the initial management of pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Elevated D-dimer and low ferritin may help predict pulmonary emboli in mild-moderate COVID-19 Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021 How to identify patients with low risk pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 603s Year: 2007 A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development Source: Eur Respir J 2003; 22: Suppl. 45, 221s Year: 2003 Carboxyhemoglobin (COHb) and bilirubin levels increase with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Acute pulmonary embolism in COPD patients Source: Annual Congress 2012 - COPD comorbidities II Year: 2012